Mary-Ellen B. Taplin

This biography of a living person includes a list of general references, but it lacks sufficient corresponding inline citations. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libelous or harmful. Please help to improve this article by introducing more precise citations. (March 2018) (Learn how and when to remove this message)

Mary-Ellen Taplin (born 1960), is a research oncologist at Dana Farber Cancer Institute and Brigham and Women's Hospital in Harvard's Longwood Medical and Academic Area.

Taplin is Institute Physician and Director of Clinical Research for the Lank Center for Genitourinary Oncology at Dana Farber Cancer Institute and at the Brigham and Women's Hospital’s Cancer Center. At the Harvard Medical School, also in the Longwood Medical Area, she is Professor of Medicine. She has been an investigator on many projects, including the Prostate Cancer Clinical Trial Consortium, Dana-Farber SPORE grant, Stand Up 2 Cancer, and several Prostate Cancer Foundation Challenge Grants.

At the Dana–Farber Cancer Institute, she chairs the Executive Committee for Clinical Research, and is Director of Clinical Research at the Lank Center for Genitourinary Oncology.^[1]